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This article describes a design and synthesis of new and versatile chiral building blocks and its application to the bio-
logically active natural product synthesis. The chiral building blocks were prepared using a biocatalysis in an enantio-
merically pure state. As an application of the above chiral building blocks to the synthesis of biologically active natural
product, we demonstrated the diastereodivergent synthesis of the 3-piperidinol alkaloids cassine, spectaline, prosafri-
nine, iso-6-cassine, prosophylline, prosopinine, and also established the ‰exible route to the 5,8-disubstituted indolizi-
dine or 1,4-disubstituted quinolizidine type of Dendrobates alkaloids. As another application to the synthesis of biologi-
cally active alkaloids, we accomplished the ˆrst enantioselective total synthesis of marine alkaloids clavepictines A, B,
and pictamine using a highly stereoselective Michael type quinolizidine ring closure reaction as the crucial step, and
the ˆrst total synthesis of a marine alkaloid lepadin B was also achieved using aldol cyclization controlled by a A(1,3)
strain.









































Fig. 1. Summary of Synthesized Alkaloids from Chiral Building Blocks 1 and 2




















Chart 2. Determination of the Absolute Stereochemistry of (＋)-1
Chart 3. Synthesis of Both Enantiomers of 2






































Chart 5. Chiral Synthesis of (－)-Cassine (3) and (＋)-Spectaline (4)
Chart 6. Chiral Synthesis of Methyl(－)-N,O-Diacetyl-
spicigerinate (36)
Chart 7. Synthesis of the Chiral Building Block (－)-37




















Chart 8. Synthesis of the Chiral Building Block (－)-39
Fig. 3. Stereochemical Course of the Reduction of (＋)-28
Chart 9. Synthesis of the Chiral Building Block (＋)-44









































Chart 10. Synthesis of the Chiral Building Block (－)-47
Chart 11. Chiral Synthesis of Prosafrinine (5) and Iso-6-Cassine (6)










Fig. 5. Strategy for the Synthesis of 5,8-Disubstituted In-
dolizidine and 1,4-Disubstituted Quinolizidine Type of Den-
drobates Alkaloids
Chart 13. Synthesis and Determination of the Stereochemistry of Trisubstituted Piperidine Ring System (＋)-54

































Table 1. Summary of the Michael Reactions
R1 X R Solvent Yield (％)
(＋)56 Et MgBr TBS THF 96
(＋)57 vinyl Li MOM Et2O 91
(＋)58 allyl MgCl MOM THF 80
(＋)59 n-Bu Li TBS Et2O 94


































clavepictine A(14), B(15), pictamine(16）の最初の
キラル合成を達成したので以下にその経緯を示す．









Chart 15. Chiral Synthesis of Indolizidine 223I (12) and C1-Epimer of Quinolizidine 207I (13)
Chart 16. Reduction of the Iminium Salt of 69
Chart 17. Reduction of the Iminium Salt of 71























移状態（A, B）が考えられるが Bでは Ha, Hb間に
hon p.10 [100%]
476
Chart 19. Intramolecular Michael Type of Cyclization of
(－)-72 Fig. 7. Stereochemical Course of the Cyclization of (－)-72





























Chart 21. Synthesis and Determination of the Stereochemistry of the Key Intermediate (＋)-81



























































209B合成中間体の 1H及び 13C NMRスペクトルを
お送り頂いた東京薬科大学，樹林千尋先生， in-
dolizidine 235B′の 1H NMRスペクトルをお送り頂
いた NIH, John W. Daly先生，clavepictine A, Bの
1H及び 13C NMRスペクトルをお送り頂いた NCI,
John H. Cardellina先生，pictamineの 1H及び 13C
NMRスペクトルをお送り頂いたカリフォルニア大
学，D. John Faulkner先生，lepadin Bトリフルオ
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